Attached files

file filename
EX-10.2 - EXHIBIT 10.2 - Sigyn Therapeutics, Inc.s104560_ex10-2.htm
EX-10.1 - EXHIBIT 10.1 - Sigyn Therapeutics, Inc.s104560_ex10-1.htm

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 3, 2016

 

Reign Sapphire Corporation

(State or other jurisdiction of incorporation)

 

Delaware 333-204486 47-2573116
(State or other jurisdiction (Commission file Number) (IRS Employer
of incorporation)   Identification No.)

 

9465 Wilshire Boulevard, Beverly Hills, CA 90212
(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (213) 457-3772

 

 

 (Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

 

 

Forward-Looking Statements

 

This Current Report on Form 8-K and other written and oral statements made from time to time by us may contain so-called “forward-looking statements,” all of which are subject to risks and uncertainties. Forward-looking statements can be identified by the use of words such as “expects,” “plans,” “will,” “forecasts,” “projects,” “intends,” “estimates,” and other words of similar meaning. One can identify them by the fact that they do not relate strictly to historical or current facts. These statements are likely to address our growth strategy, financial results and product and development programs. One must carefully consider any such statement and should understand that many factors could cause actual results to differ from our forward looking statements. These factors may include inaccurate assumptions and a broad variety of other risks and uncertainties, including some that are known and some that are not. No forward looking statement can be guaranteed and actual future results may vary materially.

 

Information regarding market and industry statistics contained in this Current Report on Form 8-K is included based on information available to us that we believe is accurate. It is generally based on industry and other publications that are not produced for purposes of securities offerings or economic analysis. We have not reviewed or included data from all sources, and cannot assure investors of the accuracy or completeness of the data included in this Current Report. Forecasts and other forward-looking information obtained from these sources are subject to the same qualifications and the additional uncertainties accompanying any estimates of future market size, revenue and market acceptance of products and services. We do not assume any obligation to update any forward-looking statement. As a result, investors should not place undue reliance on these forward-looking statements.

 

Item 1.01 Entry into a Material Definitive Agreement.

  

On November 4, 2016, the Company entered into a Binding Letter of Intent (the “LOI”) with Coordinates Collection, Inc. (“CCI”) and FD9 Group, B.V., for the acquisition of the assets of CCI by the Company, through its wholly owned subsidiary, Reign Brands, Inc. The Company created the wholly owned subsidiary for the purpose of acquiring the assets of CCI. As consideration for the acquisition of the assets of CCI, the Company shall issue an aggregate of 7,000,000 shares of common stock, shall make a cash payment of $500,000 contingent upon a future offering, and shall provide earn out payments for various sales of products. The Closing is scheduled to occur on or before December 31, 2016, and will be subject to customary closing conditions.

 

Item 2.01 Completion of Acquisition or Disposition of Assets.

 

Reference is made to the disclosure set forth under Item 1.01 of this Current Report on Form 8-K, which disclosure is incorporated herein by reference.

 

Item 3.02 Unregistered Sales of Equity Securities.

 

Reference is made to the disclosure set forth under Item 1.01 of this Current Report on Form 8-K, which disclosure is incorporated herein by reference.

 

On November 3, 2016, the Company has entered into a Consent, Waiver and Modification Agreement (the “Agreement”) with certain purchasers of convertible promissory notes pursuant to a securities purchase agreement dated December 23, 2015. The waivers contained in the Agreement were related to an increase in the shares issuable under the Company’s 2015 Stock Option Plan, a waiver of the right to participate in additional offerings by the Company, and allowing up to 20,000,000 shares of the Company’s common stock to be issued pursuant to a private or public offering at a price of not less than $0.30 per share. As consideration for the terms contained in the Agreement, as well as for a fee of $0.0001 per share, the Company shall issue an aggregate of 1,000,000 shares to the purchasers.

  

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits. The exhibits listed in the following Exhibit Index are filed as part of this Current Report on Form 8-K.

 

10.1 Binding Letter of Intent

10.2 Consent, Waiver and Modification Agreement

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  REIGN SAPPHIRE CORPORATION
   
Date:  November 4, 2016 By: /s/ Joseph Segelman
     
  Joseph Segelman, Chief Executive Officer